An international clinical trial involving UC Davis Health suggests the investigational drug Elafibranor is a potential novel treatment for patients with the rare, autoimmune disease primary biliary cholangitis. Results from ...
Nov 16, 2023
0
16
In an educational review published in the journal Pediatric Nephrology, clinicians at UC Davis and Oregon Health & Science University discuss an important procedure for children with advanced kidney disease: tidal continuous ...
Nov 15, 2023
0
10
The Food and Drug Administration (FDA) has recalled dozens of over-the-counter eye drops—artificial tears—in 2023 due to contamination and unsafe manufacturing practices. Four deaths from sepsis, 14 cases of vision loss ...
Nov 14, 2023
0
0
During the COVID-19 pandemic, telehealth emerged as a lifeline for delivering health care services, ensuring patient safety while minimizing virus transmission. However, a UC Davis Health study published in the Journal of ...
Nov 8, 2023
0
0
Domestic violence went down or stayed the same during the first 10 months of the COVID-19 pandemic in five major U.S. cities. However, domestic violence involving firearms increased in three of those cities, according to ...
Nov 1, 2023
0
0
Viral infections are known to be a central cause of more than 10% of cancers worldwide. University of California researchers may have uncovered one of the key reasons why. Their findings were published today in PLOS Pathogens.
Oct 26, 2023
0
31
When it comes to the architecture of the human genome, it's only a matter of time before harmful genes—genes that could compromise future generations—arise in a population. These mutations accumulate in the gene pool, ...
Oct 25, 2023
0
40
Zika virus infection in pregnant rhesus macaques slows fetal growth and affects how infants and mothers interact in the first month of life, according to a new study from researchers at the California National Primate Research ...
Oct 25, 2023
0
2
A new study by UC Davis Health endocrinology researchers has shown a high prevalence of thyroid cancer among transgender female veterans. It's the first evidence of such a disparity in the transgender female population in ...
Oct 24, 2023
0
0
A research team from the UC Davis Comprehensive Cancer Center has identified a crucial epitope (a protein section that can activate the larger protein) on the CD95 receptor that can cause cells to die. This new ability to ...
Oct 24, 2023
0
41
